DocumentCode
1507754
Title
Creativity is key to drug R&D
Author
Schreiner, Keri
Volume
1
Issue
3
fYear
1999
Firstpage
6
Lastpage
9
Abstract
In a world where time to market is money, the pharmaceutical industry faces special challenges. To improve their candidate drugs´ odds and decrease development time and costs, pharmaceutical companies have started to form numerous alliances with public and private institutions and launch major research and development initiatives. The author considers how scientific and computational advances have created unprecedented opportunities for innovation
Keywords
medical computing; pharmaceutical industry; research and development management; costs; drug development; pharmaceutical industry; research and development initiatives; time to market; Chemical compounds; Clinical trials; Diseases; Drugs; Genomics; Humans; Pharmaceuticals; Research and development; Safety; Time to market;
fLanguage
English
Journal_Title
Computing in Science & Engineering
Publisher
ieee
ISSN
1521-9615
Type
jour
DOI
10.1109/5992.764208
Filename
764208
Link To Document